Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 2, 2009, Pages

  Bradesi, Sylvie ^a,d   Martinez, Vicente ^b,c   Lao, Lijun ^a   Larsson, Håkan ^b   Mayer, Emeran A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corticotropin releasing factor; DMP 696; Functional gastrointestinal disorders; Irritable bowel syndrome; SSR149415

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; 8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; VASOPRESSIN V3 RECEPTOR; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CHRONIC STRESS; COLON DILATATION; CONTROLLED STUDY; FEMALE; HYPERALGESIA; HYPERSENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SENSITIZATION; SENSORIMOTOR FUNCTION; SINGLE DRUG DOSE; VISCERAL PAIN;

ANIMALS; ARGININE VASOPRESSIN; CHRONIC DISEASE; COLON; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL AGENTS; HYPERALGESIA; INDOLES; MALE; MECHANOTRANSDUCTION, CELLULAR; PAIN THRESHOLD; PRESSURE; PYRAZOLES; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN; STRESS, PSYCHOLOGICAL; TIME FACTORS; TRIAZINES;

EID: 59449093947     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90557.2008     Document Type: Article

References (54)

1. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15: 321-350, 1994.
2. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96: 23-29, 2000.
3. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119: 1276-1285, 2000.
4. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 19, Suppl 1: 62-88, 2007.
5. Barreau F, Ferrier L, Fioramonti J, Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res 62: 240-245, 2007.
6. Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 42: 414-420, 1998.
7. Bradesi S, Kokkotou E, Simeonidis S, Patierno S, Ennes HS, Mittal Y, McRoberts JA, Ohning G, McLean P, Marvizon JC, Sternini C, Pothoulakis C, Mayer EA. The role of neurokinin 1 receptors in the maintenance of visceral hyperalgesia induced by repeated stress in rats. Gastroenterology 130: 1729-1742, 2006.
8. Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 289: G42-G53, 2005.
9. th World Congress on Pain. Glasgow, Scotland, UK: August 17-22, 2008. www.iasp-pain.org.
10. Bueno L, Gue M, Delrio C. CNS vasopressin mediates emotional stress and CRH-induced colonic motor alterations in rats. Am J Physiol Gastrointest Liver Physiol 262: G427-G431, 1992.
11. Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463: 235-272, 2003.
12. Cruz CD, Avelino A, McMahon SB, Cruz F. Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation. Eur J Neurosci 21: 773-781, 2005.
13. De Goeij DCE, Jezova D, Tilders FJ. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577: 165-168, 1992.
14. De Winter RF, van Hemert AM, DeRijk RH, Zwinderman KH, Frankhuijzen-Sierevogel AC, Wiegant VM, Goekoop JG. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 28: 140-147, 2003. (Erratum in: Neuropsyc-hopharmacology 28: 610, 2003.)
15. Dinan TG, Scott LV. Anatomy of melancholia: focus on hypothalamic- pituitary-adrenal axis overactivity and the role of vasopressin. J Anat 207: 259-264, 2005.
16. Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355-357, 1982.
17. Griebel G, Simiand J, Stemmelin J, Gal CS, Steinberg R. The vasopressin V1b receptor as a therapeutic target in stress-related disorders. Curr Drug Targets CNS Neurol Disord 2: 191-200, 2003.
18. Griebel G, Stemmelin J, Gal CS, Soubrié P. Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress- related disorders. Curr Pharm Des 11: 1549-1559, 2005.
19. Harbuz MS, Lightman SL. Stress and the hypothalamo-pituitary- adrenal axis: acute, chronic and immunological activation. J Endocrinol 134: 327-339, 1992.
20. He L, Gilligan PJ, Zaczek R, Fitzgerald LW, McElroy J, Shen HS, Saye JA, Kalin NH, Shelton S, Christ D, Trainor G, Hartig P. 4-(1,3- Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]- 1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist. J Med Chem 43: 449-456, 2000.
21. Holdcroft A, Sapsed-Byrne S, Ma D, Hammal D, Forsling ML. Sex and oestrous cycle differences in visceromotor responses and vasopressin release in response to colonic distension in male and female rats anaesthetized with halothane. Br J Anaesth 85: 907-910, 2000.
22. Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura H, Vale W. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Brain Res Mol Brain Res 38: 166-170, 1996.
23. Landgraf R. The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5: 167-179, 2006.
24. Larauche M, Bradesi S, Million M, McLean P, Taché Y, Mayer EA, McRoberts JA. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol 294: G1033-G1040, 2008.
25. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button DC, Young WS 3rd, Mezey E, Brownstein MJ. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 92: 6783-6787, 1995.
26. Lolait SJ, Stewart LQ, Jessop DS, Young WS 3rd, O'Carroll AM. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148: 849 -856, 2007.
27. Martínez V, Taché Y. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Res 893: 29-35, 2001.
28. Martinez V, Taché Y.CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 12: 4071-4088, 2006.
29. Martínez V, Wang L, Taché Y. Proximal colon distension induces Fos expression in the brain and inhibits gastric emptying through capsaicin- sensitive pathways in conscious rats. Brain Res 1086: 168-180, 2006.
30. Mason D, Hassan A, Chacko S, Thompson P. Acute and chronic regulation of pituitary receptors for vasopressin and corticotropin releasing hormone. Arch Physiol Biochem 110: 74-89, 2002.
31. Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, Chang L. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 115: 398-409, 2005.
32. Mayer EA, Craske MG, Naliboff BD. Depression, anxiety and the gastrointestinal system. J Clin Psychiatry 6, Suppl 8: 28 -36, 2001.
33. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 280: G519-G524, 2001.
34. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 131: 1925-1942, 2006.
35. McElroy JF, Ward KA, Zeller KL, Jones KW, Gilligan PJ, He L, Lelas S. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic -pituitary-adrenal axis activation without sedation or ataxia in rats. Psychopharmacology (Berl) 165: 86 -92, 2002.
36. Meynen G, Unmehopa UA, van Heerikhuize JJ, Hofman MA, Swaab DF, Hoogendijk WJ. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: a preliminary report. Biol Psychiatry 60: 892-895, 2006.
37. Million M, Wang L, Martinez V, Taché Y.Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats. Brain Res 877: 345-353, 2000.
38. Monstein HJ, Truedsson M, Ryberg A, Ohlsson B. Vasopressin receptor mRNA expression in the human gastrointestinal tract. Eur Surg Res 40: 34-40, 2008.
39. Pitts AF, Samuelson SD, Meller WH, Bissette G, Nemeroff CB, Kathol RG. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biol Psychiatry 38: 330-335, 1995.
40. Price DD, Zhou Q, Moshiree B, Robinson ME, Nicholas Verne G. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain 7: 529-535, 2006.
41. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin -expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53: 137-143, 1996.
42. Ravnefjord A, Brusber M, Larsson H, Lindstrom E, Martinez V. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 155: 407-416, 2008.
43. Roux R, Serradeil-Le Gal C, Tonnerre B, Wagnon J. Novel 1,3-dihydro-2H-indol-2-0ne derivatives, preparation method and pharmaceutical compositions containing them. Patent [PCT/WO 01/5130]A2.02.082001, 2001.
44. Sato Y, Hanai H, Nogaki A, Hirasawa K, Kaneko E, Hayashi H, Suzuki Y. Role of the vasopressin V(1) receptor in regulating the epithelial functions of the guinea pig distal colon. Am J Physiol Gastrointest Liver Physiol 277: G819-G828, 1999.
45. Schang JC, Dapoigny M, Devroede G. Stimulation of colonic peristalsis by vasopressin: electromyographic study in normal subjects and patients with chronic idiopathic constipation. Can J Physiol Pharmacol 65: 2137-2141, 1987.
46. Schwetz I, Bradesi S, McRoberts JA, Sablad M, Miller JC, Zhou H, Ohning G, Mayer EA. Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors. Am J Physiol Gastrointest Liver Physiol 286: G683-G691, 2004.
47. Serradeil-Le Gal C, Derick S, Brossard G, Manning M, Simiand J, Gaillard R, Griebel G, Guillon G. Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals. Stress 6: 199 -206, 2003.
48. Serradeil-Le Gal C, Wagnon J 3rd, Tonnerre B, Roux R, Garcia G, Griebel G, Aulombard A. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 11: 53-68, 2005.
49. Solmaz M, Kavuk I, Sayar K. Psychological factors in the irritable bowel syndrome. Eur J Med Res 8: 549-556, 2003.
50. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract. III. Stress-related alterations of gut motor function: role of brain corticotropin- releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 280: G173-G177, 2001.
51. Tammpere A, Brusberg M, Axenborg J, Hirsch I, Larsson H, Lindström E. Evaluation of pseudo-affective responses to noxious colorectal distension in rats by manometric recordings. Pain 116: 220 -226, 2005.
52. Vaccari C, Lolait SJ, Ostrowski NL. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 139: 5015-5033, 1998.
53. Wang Z, Bradesi S, Maarek JM, Lee K, Winchester WJ, Mayer EA, Holschneider DP. Regional brain activation in conscious, nonrestrained rats in response to noxious visceral stimulation. Pain 138: 233-243, 2008.
54. Zhu YR, Cowles VE, Herranz ES, Schulte WJ, Condon RE. Arginine vasopressin inhibits phasic contractions and stimulates giant contractions in monkey colon. Gastroenterology 102: 868 -874, 1992.